CALCA and migraine disorder: All patients filled out the Migraine Treatment Optimization Questionnaire (MTOQ), the Headache Impact Test (HIT-6), and the Migraine Impact and Disability Assessment Scale (MIDAS) at baseline and 3-6 months after the start of treatment with CGRP-mAbs.<h4>Results</h4>Sixty-five patients (81.3%) completed the 6-month follow-up.